56 OBESITÀ: DA AMPLIFICATORE DI RISCHIO A MALATTIA CRONICA 5. Jones DW, Kim JS, Andrew ME, et al. Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens. 1994;12:1433-7. 6. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II. Ann Intern Med. 2001;134:1-11. 7. Stefan N, Haring HU, Hu FB, et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152-62. 8. Grassi G, Cattaneo BM, Seravalle G, et al. Obesity and the sympathetic nervous system. Blood Press. 1996;1 (suppl):43-46. 9. Grassi G, Dell’Oro R, Facchini A, et al. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens. 2004;22:2363-9. 10. Grassi G, Biffi A, Seravalle G, et al. Sympathetic neural overdrive in the obese and overweight state. Meta-analysis of published studies. Hypertension. 2019;74:349-358. 11. Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metab Clin Exp. 2019;92:6-10. 12. Barsh GS, Farooqi IS, O’Rahilly S. Genetics of body weight regulation. Nature. 2000;404:644-51. 13. Wardle J, Carnell S, Haworth CM et al. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr. 2008;87:398-404. 14. Di Angelantonio E, Bhupathiraju SHN, Wormser D et al. Body-mass index and all-cause mortality: individual-participant-data-metanalysis of 239 prospective studies in four continents. Lancet. 2016;388:776-86. 15. Hu H, Wang J, Han X, et al. Prediction of 5-year risk of diabetes mellitus in relatively low risk middle-aged and elderly adults. Acta Diabetol. 2020;57:63-70. 16. Seven E, Thuesen BH, Linneberg A, et al. Abdominal adiposity distribution quantified by ultrasound imaging and incident hypertension in a general population. Hypertension. 2016;68:1115-22. 17. Kotsis V, Jordan J, Micic D, et al. Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patients and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes, and dyslipidemia and practice guidelines for treatment. J Hypertens. 2018;36:1427-40. 18. Seravalle G, Colombo M, Perego P, et al. Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients. Hypertension. 2014;64:431-7. 19. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology nd the European Society of Hypertension. J Hypertens. 2018;36:1953-2041. 20. Parati G, Stergiou GS, O’Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359-66. 21. Mancia G, Facchetti R, Seravalle G, et al. Adding home and/or ambulatory blood pressure to office blood pressure for cardiovascular risk prediction. Hypertension. 2021;77:640-9. 22. Akpolat T. Obesity, hypertension and home sphygmomanometer cuffs. Eur J Int Med. 2010;21:338-40. 23. Palatini P, Benetti E, Fania C, et al. Only troncoconical cuffs can provide accurate blood pressure measurements in people with severe obesity. J Hypertens. 2019;37:37-41. 24. Seravalle G, Grassi G. Sleep apnea and hypertension. High Blood Press Cardiovasc Prev. 2021 25. Grassi G, Facchini A, Quarti-Trevano F, et al. Obstructive sleep apneas-dependent and -independent adrenergic activation in obesity. Hypertension. 2005;46:321-5. 26. Quarti-Trevano F, Biffi A, Bonzani M, et al. Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis. J Hypertens. 2021;39:2281-9 27. Belaidi E, Joyeux-Faure C, Ribout SH, et al. Major role for hypoxia inducible factor-1 and the
RkJQdWJsaXNoZXIy NDUyNTU=